Product NDC: | 0069-0080 |
Proprietary Name: | Mitoxantrone Hydrochloride |
Non Proprietary Name: | Mitoxantrone Hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; Mitoxantrone Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0080 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201014 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121212 |
Package NDC: | 0069-0080-01 |
Package Description: | 10 mL in 1 VIAL (0069-0080-01) |
NDC Code | 0069-0080-01 |
Proprietary Name | Mitoxantrone Hydrochloride |
Package Description | 10 mL in 1 VIAL (0069-0080-01) |
Product NDC | 0069-0080 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mitoxantrone Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121212 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | MITOXANTRONE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |